Skip to main content

Navigation group

Type at least 3 characters
321 articles

Articles

Systematic Review

Published on 26 Aug 2024

Mirabegron 50 mg once daily, long-term treatment maximizes benefit in middle-aged and older people with overactive bladder syndrome: a systematic review and meta-analysis of nine phase II/III, randomized, double-blind, parallel-design, placebo-controlled, multicenter, and multinational trials

in Genitourinary Surgery

  • Xiangxiang Zhang
  • Yinhui Mao
  • Yang Liu
  • Jilei Sun
  • Juntao Sun
  • Chenli Pan
  • Zhuo Wang
  • Zhitao Wei
  • Yong Yang
Mirabegron 50 mg once daily, long-term treatment maximizes benefit in middle-aged and older people with overactive bladder syndrome: a systematic review and meta-analysis of nine phase II/III, randomized, double-blind, parallel-design, placebo-controlled, multicenter, and multinational trials
Frontiers in Surgery
doi 10.3389/fsurg.2024.1372175
  • 883 views